Development and feasibility testing of a lung cancer screening decision aid

肺癌筛查决策辅助工具的开发和可行性测试

• 批准号: 8791650
• 负责人: Margaret M Byrne
• 金额: $ 16.24万
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-01-15 至 2016-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8791650
• 关键词: Address; American; American Cancer Society; American Lung Association; Area; Benefits and Risks; Cancer Etiology; Cessation of life; Cigarette Smoker; Communication; Complex; County; Data; Decision Aid; Decision Making; Development; Diagnosis; Dose; Effectiveness; Eligibility Determination; Ensure; Feedback; Funding; Future; Guidelines; Health; Health Personnel; Healthcare Systems; Individual; Internet; Intervention; Kentucky; Knowledge; Lung; Malignant neoplasm of lung; Methodology; Methods; Modification; National Comprehensive Cancer Network; Online Systems; Outcome; Participant; Population; Procedures; Process; Public Health; Qualifying; Radiation; Randomized Clinical Trials; Recommendation; Recruitment Activity; Relative (related person); Reporting; Research; Risk; Smoke; Surveys; Technology; Testing; Thoracic Radiography; Uncertainty; United States; Work; X-Ray Computed Tomography; base; cancer risk; cigarette smoking; community setting; decision research; design; empowerment; follow-up; high risk; improved; innovation; instrument; interest; lung cancer screening; meetings; mortality; novel strategies; preference; programs; psychosocial; screening; tool; usability

DESCRIPTION (provided by applicant): The proposed project will develop an innovative web-based decision aid (DA) to improve decision making for lung cancer screening (LCS) among individuals at high risk for lung cancer due to cigarette smoking. Recent National Lung Screening Trial (NLST) data demonstrated a 20% relative reduction in lung cancer mortality for low dose computed tomography screening as compared to chest X-ray among individuals at high lung cancer risk. Given that lung cancer is the leading cause of cancer death in the United States with an estimated 160,340 deaths predicted for 2012, the new data have reinvigorated interest in LCS. However, LCS carries substantial risks including a high false positive rate, over-diagnosis, adverse psychosocial consequences, and increased radiation exposure. Further, it is unknown whether LCS would reduce lung cancer mortality among individuals who smoke but do not meet NLST eligibility criteria. Therefore, there is currently no clear best choice for whether given individual should be screened or not. Decisions about participating in LCS should be well informed and consistent with individual preferences. However, our previous data indicate that individuals who do undergo LCS rarely have a thorough understanding of the risks or benefits. To address this rapidly emerging public health challenge, this research will 1) develop a web-based decision aid (DA) to facilitate informed decision making regarding LCS in individuals at high risk for lung cancer (i.e., cigarette smokers), and 2) assess feasibility of DA administration and proposed methods for conducting a future randomized clinical trial (RCT) of DA effectiveness. The content of the DA will be based on our previous studies exploring LCS decision making and other recent research. The specific aims of the currently proposed research are: Aim 1: Develop a DA to help individuals make informed decisions about LCS that are consistent with their values and preferences. We will develop the DA based on our previously developed KEV framework and guided by previous research, including our program of LCS decision research. Aim 2: Conduct a feasibility trial of the DA among individuals at high risk of lung cancer due to heavy cigarette smoking. We will recruit participants to assess feasibility of: 1) delivering the DA intervention i a community setting, and 2) conducting research procedures and assessment tools as planned for a future RCT. Our proposed work is highly significant, as the potential risks and limitations of LCS are substantial, the benefits of screening for populations outside the NLST criteria are uncertain, and millions of Americans will be facing decisions about screening. Our work is also highly innovative, as a LCS-DA can fundamentally improve the way these decisions are made. In addition, integrating a conjoint survey instrument as part of a DA for LCS is a novel approach to facilitate informed decision making among this large, high-risk population.

描述(由申请人提供)：拟议的项目将开发一个创新的基于网络的决策辅助(DA)，以改善因吸烟而导致肺癌高危人群的肺癌筛查(LCS)决策。最近的国家肺部筛查试验(NLST)数据显示，在肺癌高危人群中，低剂量计算机断层扫描筛查的肺癌死亡率与胸部X光相比相对降低了20%。鉴于肺癌是美国癌症死亡的主要原因，预计2012年将有160340人死于肺癌，新数据重新激发了人们对LC的兴趣。然而，LCS具有很大的风险，包括高假阳性率、过度诊断、不良的心理社会后果和增加辐射暴露。此外，目前尚不清楚LCS是否会降低吸烟但不符合NLST资格标准的个人的肺癌死亡率。因此，对于是否应该对特定的个人进行筛查，目前还没有明确的最佳选择。关于参与LCS的决定应该得到充分的信息，并与个人偏好保持一致。然而，我们之前的数据表明，接受LCS的人很少对风险或好处有透彻的了解。为了应对这一迅速出现的公共卫生挑战，本研究将1)开发基于网络的决策辅助(DA)，以促进肺癌高危人群(即吸烟者)关于LCS的知情决策，以及2)评估DA管理的可行性 并提出了未来进行DA有效性的随机临床试验(RCT)的方法。DA的内容将基于我们之前探索LCS决策的研究和其他最近的研究。目前拟议的研究的具体目标是：目标1：发展发展议程，帮助个人做出与其价值观和偏好一致的关于LCS的明智决定。我们将基于我们之前开发的KEV框架，并以之前的研究为指导，包括我们的LCS决策研究计划，来开发DA。目标2：开展 在吸烟严重的肺癌高危人群中应用DA的可行性试验。我们将招募参与者来评估以下方面的可行性：1)在社区环境下提供发展援助干预，以及2)按计划为未来的随机对照试验进行研究程序和评估工具。我们的 拟议的工作意义重大，因为LCS的潜在风险和局限性是巨大的， 对NLST标准以外的人群进行筛查的好处是不确定的，数百万美国人将面临有关筛查的决定。我们的工作也是高度创新的，因为LCS-DA可以从根本上改进这些决策的做出方式。此外，将联合调查工具整合为LCS发展议程的一部分，是在这一庞大的高危人群中促进知情决策的一种新方法。